Glucodigifucoside
CAS: 2446-63-1
Ref. 3D-CAA44663
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
- 5β-Card-20(22)-enolide, 3β-[(6-deoxy-4-O-β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-14-hydroxy-
- (3β,5β)-3-[(6-Deoxy-4-O-β-D-glucopyranosyl-L-galactopyranosyl)oxy]-14-hydroxycard-20(22)-enolide
- Card-20(22)-enolide, 3-[(6-deoxy-4-O-β-D-glucopyranosyl-L-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β)-
Glucodigifucoside is a purpurea that has been shown to have cytotoxic effects against cancer cells. It has been found to be a potent cytotoxic agent, which inhibits the growth of tumour cells in vitro and in vivo. The structure of glucodigifucoside was determined by NMR spectroscopy, and it was found to bear a close resemblance to lanatosides A and B, cardenolides, and cardiac glycosides. Glucodigifucoside also contains six hydroxyl groups, which can be acetylated with acetic anhydride.
Chemical properties
Technical inquiry about: 3D-CAA44663 Glucodigifucoside
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
